Auricular Vagus Stimulation and Heart Rate Variability
Transcutaneous Electrical Auricular Vagus Stimulation and Heart Rate Variability
Bakulev Scientific Center of Cardiovascular Surgery
600 participants
Dec 1, 2022
INTERVENTIONAL
Conditions
Summary
Transcutaneous electrical stimulation of the auricular vagus nerve (TENS) is a promising method of neuromodulation of the autonomic nervous system in patients with various pathologies. The use of this method requires the determination of a reliable biomarker of successful activation of the vagus nerve using TENS. Currently, most studies focus on the assessment of heart rate variability (HRV) as a marker of the functioning of the autonomic nervous system. Despite the physiological justification of HRV as a biomarker for TENS, the data on the effects of TENS on HRV are ambiguous. In some studies, a significant decrease in the ratio of spectral characteristics (LF/HF) in active TENS was found in comparison with fictitious stimulation (sham), which indicated an increase in the parasympathetic component of HRV. However, other studies have not revealed an increase in HRV.
Eligibility
Inclusion Criteria1
- Sinus rhythm at the time of registration
Exclusion Criteria4
- Frequent ventricular / supraventricular extrasystole, 2d/3d degree AV Block
- Taking glucocorticosteroids in the last 1 month
- Taking any antiarrhythmics, except beta blockers
- Severe chronic renal or liver pathology
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
TENS stimulation will occur within 10 minutes. HRV parameters will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05680337